Literature DB >> 22764654

[Clinical significance of pharmacogenetics in dermatological diseases].

Mariola Rychlik-Sych1, Małgorzata Barańska, Jadwiga Skritkowicz.   

Abstract

The etiology of dermatological diseases is still unknown. Involvement of genetic and environmental factors in the pathogenesis of dermatological diseases has contributed to a number of studies whose aim is to elucidate the way in which xenobiotics exert effects on the occurrence of these diseases. The search for genes responsible for dermatological diseases is taking into consideration polymorphism of genes of cytochrome P450 (CYP), NAT2 (N-acetylotransferase 2), GST (glutatione S-transferase).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764654

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  2 in total

1.  Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Celina Kruszniewska-Rajs; Andrzej Swinarew; Krzysztof Jasik; Beata Rozwadowska; Agata Krawczyk
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

2.  Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Andrzej S Swinarew; Beata Rozwadowska; Nikola Zmarzły; Joanna Gola
Journal:  Postepy Dermatol Alergol       Date:  2020-05-06       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.